Cooper Companies ($COO) reported Q2 results that highlighted continued strength across its healthcare and medical device businesses. Demand for contact lenses and women's health products remained a key growth driver, helping the company maintain momentum in a resilient healthcare market. Investors are also watching margins, cost management, and future guidance as Cooper looks to build on its steady long-term growth story. With healthcare demand staying strong, $COO continues to be one of the names benefiting from defensive growth trends.